Advanced search
Publication Cover
Journal of Investigative Surgery Volume 25, 2012 - Issue 2
Submit an article Journal homepage
207
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Neuroblastoma Management in Chinese Children

Kai LiChildren's Hospital of Fudan University, Shanghai, P. R. China
, MD,
Kuiran DongChildren's Hospital of Fudan University, Shanghai, P. R. ChinaCorrespondence[email protected]
, MD,
Jiechun GaoChildren's Hospital of Fudan University, Shanghai, P. R. China
, MD,
Wei YaoChildren's Hospital of Fudan University, Shanghai, P. R. China
, MD,
Xianmin XiaoChildren's Hospital of Fudan University, Shanghai, P. R. China
, MD &
Shan ZhengChildren's Hospital of Fudan University, Shanghai, P. R. China
, MD
Pages 86-92 | Received 28 Jan 2011, Accepted 11 Jul 2011, Published online: 22 Mar 2012

REFERENCES

  • Hammond D. Multidisciplinary teamwork in the management of childhood cancer. Calif Med. 1972;116(3):74–75.
  • Maris JM. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr. 2005;17(1):7–13.
  • Castleberry RP, Pritchard J, Ambros P, The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer 1997;33(12):2113–2116.
  • Attiyeh EF, London WB, Mosse YP, Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005;353(21):2243–2253.
  • Kaneko M, Tsuchida Y, Uchino J, Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol. 1999;21(3):190–197.
  • Iwafuchi M, Utsumi J, Tsuchida Y, Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma. Med Pediatr Oncol. 1996;27(6):515–520.
  • Castel V, Garcia-Miguel P, Canete A, Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting. Eur J Cancer. 1999;35(4):606–611.
  • Hobbie WL, Moshang T, Carlson CA, Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma. Pediatr Blood Cancer. 2008;51(5):679–683.
  • Fredlund E, Ringner M, Maris JM, High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci U S A. 2008;105(37):14094–14099.
  • Breslow N, McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res. 1971;31(12):2098–2103.
  • Thomas PR, Lee JY, Fineberg BB, An analysis of neuroblastoma at a single institution. Cancer. 1984;53(10):2079–2082.
  • London WB, Castleberry RP, Matthay KK, Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol. 2005;23(27):6459–6465.
  • London WB, Boni L, Simon T, The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. Cancer Lett. 2005;228(1–2):257–266.
  • Aydin GB, Kutluk MT, Yalcin B, The prognostic significance of vanillylmandellic acid in neuroblastoma. Pediatr Hematol Oncol. 2010;27(6):435–448.
  • Kushner BH, Cheung NK. Induction for high-risk neuroblastoma. Pediatr Blood Cancer. 2007;49(3):221–223.
  • Tsuchida Y, Kaneko M. Surgery in pediatric solid tumors with special reference to advanced neuroblastoma. Acta Paediatr Taiwan. 2002;43(2):67–71.
  • Yokoyama J, Ikawa H, Endow M, The role of surgery in advanced neuroblastoma. Eur J Pediatr Surg. 1995;5(1):23–26.
  • Cantos MF, Gerstle JT, Irwin MS, Surgical challenges associated with intensive treatment protocols for high-risk neuroblastoma. J Pediatr Surg. 2006;41(5):960–965.
  • La Quaglia MP, Kushner BH, Su W, The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg. 2004;39(3):412–417.
  • Pai Panandiker AS, McGregor L, Krasin MJ, Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma. Int J Radiat Oncol Biol Phys. 2010;76(4):1161–1165.
  • Sposto R, London WB, Alonzo TA. Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group. J Clin Oncol. 2007;25(15):2070–2077.
  • Tsuchida Y, Shitara T, Kuroiwa M, Current treatment and future directions in neuroblastoma. Indian J Pediatr. 2003;70(10):809–812.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.